3 min read

Active Motif & OnRamp Announce Partnership

By Jeremy Davis-Turak on Dec 12, 2018 7:37:00 AM

OnRamp’s ROSALIND and Active Motif offer an improved ChIP-Seq data analysis experience for researchers with state-of-the-art dynamic track plots and advanced collaboration capabilities.

FOR IMMEDIATE RELEASE

San Diego, California – December 12, 2018 - OnRamp BioInformatics, a genomics company focused on scientist-friendly bioinformatics software solutions, today announced they are working with Active Motif to improve accuracies in data analysis for ChIP-Seq experiments.

OnRamp’s flagship software, ROSALIND, provides a point-and-click experience to speed up and simplify the process of genomic data analysis from experiment setup to QC and interactive data visualization to interpretation. With this integration, researchers will now benefit from an optimized analysis that includes the unique characteristics of Active Motif kits and antibodies, including Unique Molecular Identifiers (UMI) and spike-in solutions.

Download The One-Sheet

Topics: Big Data Personalized Medicine Cancer BioInformatics Biology Rosalind advaita
2 min read

ROSALIND WINS BEST OF SHOW AT BIO-IT WORLD 2018

By Jean Lozach on Jun 8, 2018 9:43:00 AM

OnRamp takes home the "People's Choice - Best of Show" award at BioIT-World 2018 in Boston.
Click here to try ROSALIND for free
Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
4 min read

Come See ROSALIND at Bio-IT World 2018

By Jean Lozach on May 11, 2018 1:52:23 PM

As proud contender for Bio-IT World's "People's Choice - Best in Show", ROSALIND will have latest features presented throughout the event

Event: Bio-IT World

Dates: 5/15/18 - 5/17/18

Location: Seaport World Trade Center, Boston MA

Event URL: www.bio-itworld.com/

Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
4 min read

Decoding Human Health

By Jeremy Davis-Turak on May 3, 2018 9:10:20 AM

OnRamp and Advaita announce a Strategic Partnership to bring collaboration and widespread accessibility to genomic data analysis

San Diego, CA – May 3, 2018 OnRamp Bioinformatics, Inc., a genomics company providing the premier scientist-focused data analysis platform, and Advaita BioInformatics, a leader in personalized medicine and interpretation of Next-Gen Sequencing data, announced they are partnering to provide a comprehensive research experience from sample to interpretation with a seamless handoff between systems.  

OnRamp.Bio’s flagship product, ROSALIND™, enables researchers, drug developers and bench scientists to analyze raw genomics data by providing a transformative experience through point-and-click experiment set up, interactive data visualization and interpretation. This new approach increases productivity by freeing up time for the bioinformatician to focus on more challenging workloads, while making bioinformatic analysis more accessible for the scientist to do more discovery with their data.

Topics: Big Data Personalized Medicine Cancer BioInformatics Biology Rosalind advaita
1 min read

ROSALIND Featured at #TRICON 2018!

By Jean Lozach on Feb 6, 2018 1:29:39 PM

OnRamp's CEO, Tim Wesselman, features ROSALIND™ during Plenary Keynote Panel on Emerging Technologies and Industry Perspectives

Event: Molecular Medicine Tri-Conference

Date/Time: February 14th @ 8:45a PT

Location: San Francisco Moscone Convertion Hall

Event URL: http://www.triconference.com/

Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
3 min read

OnRamp Featured in Huffington Post

By Dr. Robi Ludwig on Nov 17, 2017 1:13:11 PM

Dr. Robi Ludwig interviews OnRamp CEO, Tim Wesselman, to explore the future needs for genomics to scale.

Tim Wesselmanthe Chief Executive Officer of OnRamp.Bio, is on a mission to streamline, simplify and revolutionize the way we currently analyze and store genomic data, the data found within the DNA of every living thing.

You might be thinking, why is this so important? Well, this form of analysis allows researchers, biologists and drug developers to access the genomic information they need, which will permit them to achieve greater discoveries; discoveries that will benefit both individuals and society.

Wesselman spent the last two decades as a senior executive in top technology companies working on next generation data management and storage solutions (called hyper-scale). He is a graduate of multiple executive programs in Finance, Accounting, Investor Relations and Strategic Marketing from Columbia University, Rice University and University of Michigan and holds a B.S. Mechanical Engineering degree from Texas A&M University. Wesselman believes that software innovation will allow researchers to be in control of their own research, in a way that they aren’t now, enabling them to operate at a speed more in sync with today’s modern world’s pace: A pace which is becoming exponentially faster all of the time.

After a frightening experience Tim Wesselman had with the safety of his third unborn child who was medically at risk, he became even more determined to improve upon the research around this scientific quagmire when it came to obtaining genomic results for personalize medicine and patient care. The incident concerning his unborn child further underscored his belief that the inner secrets of life encoded in DNA, especially when it comes to disease and environment, are far too important to not be translated in a way that makes the most sense. In a way that facilitates the greatest minds of our time to find the answers, cures, and treatment impacting our current and future society.

Tim Wesselman and I got into more details about this intriguing and very modern scientific topic during our interview here.

Topics: Big Data Personalized Medicine Cancer BioInformatics Biology Rosalind
1 min read

Meet  Rosalind™ in Orlando at ASHG 2017!

By Tim Wesselman on Oct 4, 2017 1:58:00 PM

OnRamp BioInformatics welcomes you to visit us at the ASHG Data CoLab zone Oct 18th, 19th and 20th to Meet Rosalind™. 

This new platform was built with the researcher/biologist in mind, guiding you through a simplified bioinformatics process from experimental design to interpretation for analyses including transcriptomics and epigenetics. 

Topics: Personalized Medicine Transcriptome BioInformatics Rosalind Epigenetics
3 min read

Complexity & Data Sharing

By Tim Wesselman on May 15, 2017 12:49:00 PM

Good News Bad News for Personalized Medicine.

I’m reminded daily of the many advancements towards personalized medicine, but one elephant remains firmly planted in the room.

Recently I came across an encouraging article that touched on the increasingly collaborative nature of the efforts to bring about this new age of personalized medicine.  Data-sharing is reported to be on the rise in oncology, with groups like the Genomic Data Commons assembling harmonized genomic and clinical datasets, and making that information widely accessible to cancer researchers. 

Topics: Big Data Personalized Medicine